Brief: CARsgen Therapeutics Entering Into Strategic Cooperation Agreements
13/02/2026 24:06
Feb 13 (Reuters) - CARsgen Therapeutics Holdings Ltd 2171.HK: ENTERING INTO STRATEGIC COOPERATION AGREEMENTS CO WILL ESTABLISH ADVANCED COMMERCIAL MANUFACTURING BASE FOR CAR T-CELL PRODUCTS IN JINSHAN DISTRICT, SHANGHAI INVESTMENT OF RMB370 MLN FOR MANUFACTURING BASE IN SHANGHAI Further company coverage: 2171.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on CARsgen Therapeutics Holdings
See all newsBrief: Carsgen Therapeutics Says CT1190B Receives IND Clearance From NMPA For Relapsed/Refractory Large B-Cell Lymphoma
Brief: Carsgen Therapeutics Says CT0596 Receives IND Clearance From NMPA
Brief: Carsgen Therapeutics Approves Share Repurchase Plan For Up To 30.12 Million Shares
CARsgen Therapeutics climbs on board nod for share buyback
Brief: Carsgen Therapeutics Says NMPA Approves Satricabtagene Autoleucel For Advanced Gastric Cancer